United States Furosemide Market Report 2018

March 2018 | 102 pages | ID: U23779BE86CQEN
QYResearch

Abstracts

In this report, the United States Furosemide market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Furosemide in these regions, from 2013 to 2025 (forecast).

United States Furosemide market competition by top manufacturers/players, with Furosemide sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi Aventis
• US Pharm Holdings
• Mylan
• Sandoz
• Hospira
• West-Ward Pharms
• Ivax Sub Teva Pharms
• Emcure Pharms
• Sun Pharm Inds

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Injection
• Solution
• Tablet

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy
• Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Furosemide Market Report 2018

1 FUROSEMIDE OVERVIEW

1.1 Product Overview and Scope of Furosemide
1.2 Classification of Furosemide by Product Category
  1.2.1 United States Furosemide Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Furosemide Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Injection
  1.2.4 Solution
  1.2.5 Tablet
1.3 United States Furosemide Market by Application/End Users
  1.3.1 United States Furosemide Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Clinics
1.4 United States Furosemide Market by Region
  1.4.1 United States Furosemide Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Furosemide Status and Prospect (2013-2025)
  1.4.3 Southwest Furosemide Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Furosemide Status and Prospect (2013-2025)
  1.4.5 New England Furosemide Status and Prospect (2013-2025)
  1.4.6 The South Furosemide Status and Prospect (2013-2025)
  1.4.7 The Midwest Furosemide Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Furosemide (2013-2025)
  1.5.1 United States Furosemide Sales and Growth Rate (2013-2025)
  1.5.2 United States Furosemide Revenue and Growth Rate (2013-2025)

2 UNITED STATES FUROSEMIDE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Furosemide Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Furosemide Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Furosemide Average Price by Players/Suppliers (2013-2018)
2.4 United States Furosemide Market Competitive Situation and Trends
  2.4.1 United States Furosemide Market Concentration Rate
  2.4.2 United States Furosemide Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Furosemide Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES FUROSEMIDE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Furosemide Sales and Market Share by Region (2013-2018)
3.2 United States Furosemide Revenue and Market Share by Region (2013-2018)
3.3 United States Furosemide Price by Region (2013-2018)

4 UNITED STATES FUROSEMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Furosemide Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Furosemide Revenue and Market Share by Type (2013-2018)
4.3 United States Furosemide Price by Type (2013-2018)
4.4 United States Furosemide Sales Growth Rate by Type (2013-2018)

5 UNITED STATES FUROSEMIDE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Furosemide Sales and Market Share by Application (2013-2018)
5.2 United States Furosemide Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES FUROSEMIDE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi Aventis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Furosemide Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Aventis Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 US Pharm Holdings
  6.2.2 Furosemide Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 US Pharm Holdings Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Mylan
  6.3.2 Furosemide Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Mylan Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sandoz
  6.4.2 Furosemide Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sandoz Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Hospira
  6.5.2 Furosemide Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Hospira Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 West-Ward Pharms
  6.6.2 Furosemide Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 West-Ward Pharms Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Ivax Sub Teva Pharms
  6.7.2 Furosemide Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Ivax Sub Teva Pharms Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Emcure Pharms
  6.8.2 Furosemide Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Emcure Pharms Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Sun Pharm Inds
  6.9.2 Furosemide Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sun Pharm Inds Furosemide Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 FUROSEMIDE MANUFACTURING COST ANALYSIS

7.1 Furosemide Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Furosemide

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Furosemide Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Furosemide Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES FUROSEMIDE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Furosemide Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Furosemide Sales Volume Forecast by Type (2018-2025)
11.3 United States Furosemide Sales Volume Forecast by Application (2018-2025)
11.4 United States Furosemide Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Furosemide
Figure United States Furosemide Market Size (K Units) by Type (2013-2025)
Figure United States Furosemide Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Solution Product Picture
Figure Tablet Product Picture
Figure United States Furosemide Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Furosemide by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure United States Furosemide Market Size (Million USD) by Region (2013-2025)
Figure The West Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Furosemide Sales (K Units) and Growth Rate (2013-2025)
Figure United States Furosemide Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Furosemide Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Furosemide Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Furosemide Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Furosemide Sales Share by Players/Suppliers
Figure 2017 United States Furosemide Sales Share by Players/Suppliers
Figure United States Furosemide Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Furosemide Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Furosemide Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Furosemide Revenue Share by Players/Suppliers
Figure 2017 United States Furosemide Revenue Share by Players/Suppliers
Table United States Market Furosemide Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Furosemide Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Furosemide Market Share of Top 3 Players/Suppliers
Figure United States Furosemide Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Furosemide Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Furosemide Product Category
Table United States Furosemide Sales (K Units) by Region (2013-2018)
Table United States Furosemide Sales Share by Region (2013-2018)
Figure United States Furosemide Sales Share by Region (2013-2018)
Figure United States Furosemide Sales Market Share by Region in 2017
Table United States Furosemide Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Furosemide Revenue Share by Region (2013-2018)
Figure United States Furosemide Revenue Market Share by Region (2013-2018)
Figure United States Furosemide Revenue Market Share by Region in 2017
Table United States Furosemide Price (USD/Unit) by Region (2013-2018)
Table United States Furosemide Sales (K Units) by Type (2013-2018)
Table United States Furosemide Sales Share by Type (2013-2018)
Figure United States Furosemide Sales Share by Type (2013-2018)
Figure United States Furosemide Sales Market Share by Type in 2017
Table United States Furosemide Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Furosemide Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Furosemide by Type (2013-2018)
Figure Revenue Market Share of Furosemide by Type in 2017
Table United States Furosemide Price (USD/Unit) by Types (2013-2018)
Figure United States Furosemide Sales Growth Rate by Type (2013-2018)
Table United States Furosemide Sales (K Units) by Application (2013-2018)
Table United States Furosemide Sales Market Share by Application (2013-2018)
Figure United States Furosemide Sales Market Share by Application (2013-2018)
Figure United States Furosemide Sales Market Share by Application in 2017
Table United States Furosemide Sales Growth Rate by Application (2013-2018)
Figure United States Furosemide Sales Growth Rate by Application (2013-2018)
Table Sanofi Aventis Basic Information List
Table Sanofi Aventis Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Aventis Furosemide Sales Growth Rate (2013-2018)
Figure Sanofi Aventis Furosemide Sales Market Share in United States (2013-2018)
Figure Sanofi Aventis Furosemide Revenue Market Share in United States (2013-2018)
Table US Pharm Holdings Basic Information List
Table US Pharm Holdings Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure US Pharm Holdings Furosemide Sales Growth Rate (2013-2018)
Figure US Pharm Holdings Furosemide Sales Market Share in United States (2013-2018)
Figure US Pharm Holdings Furosemide Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Furosemide Sales Growth Rate (2013-2018)
Figure Mylan Furosemide Sales Market Share in United States (2013-2018)
Figure Mylan Furosemide Revenue Market Share in United States (2013-2018)
Table Sandoz Basic Information List
Table Sandoz Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sandoz Furosemide Sales Growth Rate (2013-2018)
Figure Sandoz Furosemide Sales Market Share in United States (2013-2018)
Figure Sandoz Furosemide Revenue Market Share in United States (2013-2018)
Table Hospira Basic Information List
Table Hospira Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hospira Furosemide Sales Growth Rate (2013-2018)
Figure Hospira Furosemide Sales Market Share in United States (2013-2018)
Figure Hospira Furosemide Revenue Market Share in United States (2013-2018)
Table West-Ward Pharms Basic Information List
Table West-Ward Pharms Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure West-Ward Pharms Furosemide Sales Growth Rate (2013-2018)
Figure West-Ward Pharms Furosemide Sales Market Share in United States (2013-2018)
Figure West-Ward Pharms Furosemide Revenue Market Share in United States (2013-2018)
Table Ivax Sub Teva Pharms Basic Information List
Table Ivax Sub Teva Pharms Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ivax Sub Teva Pharms Furosemide Sales Growth Rate (2013-2018)
Figure Ivax Sub Teva Pharms Furosemide Sales Market Share in United States (2013-2018)
Figure Ivax Sub Teva Pharms Furosemide Revenue Market Share in United States (2013-2018)
Table Emcure Pharms Basic Information List
Table Emcure Pharms Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Emcure Pharms Furosemide Sales Growth Rate (2013-2018)
Figure Emcure Pharms Furosemide Sales Market Share in United States (2013-2018)
Figure Emcure Pharms Furosemide Revenue Market Share in United States (2013-2018)
Table Sun Pharm Inds Basic Information List
Table Sun Pharm Inds Furosemide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sun Pharm Inds Furosemide Sales Growth Rate (2013-2018)
Figure Sun Pharm Inds Furosemide Sales Market Share in United States (2013-2018)
Figure Sun Pharm Inds Furosemide Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Furosemide
Figure Manufacturing Process Analysis of Furosemide
Figure Furosemide Industrial Chain Analysis
Table Raw Materials Sources of Furosemide Major Players/Suppliers in 2017
Table Major Buyers of Furosemide
Table Distributors/Traders List
Figure United States Furosemide Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Furosemide Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Furosemide Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Furosemide Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Furosemide Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Furosemide Sales Volume (K Units) Forecast by Type in 2025
Table United States Furosemide Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Furosemide Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Furosemide Sales Volume (K Units) Forecast by Application in 2025
Table United States Furosemide Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Furosemide Sales Volume Share Forecast by Region (2018-2025)
Figure United States Furosemide Sales Volume Share Forecast by Region (2018-2025)
Figure United States Furosemide Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources